QHSLab Past Earnings Performance
Past criteria checks 0/6
QHSLab's earnings have been declining at an average annual rate of -66.4%, while the Medical Equipment industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 91.6% per year.
Key information
-66.4%
Earnings growth rate
-55.5%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | 91.6% |
Return on equity | -129.2% |
Net Margin | -59.6% |
Last Earnings Update | 31 Mar 2022 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How QHSLab makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 22 | 1 | -1 | 1 | 0 |
31 Dec 21 | 1 | -1 | 1 | 0 |
30 Sep 21 | 1 | -1 | 1 | 0 |
30 Jun 21 | 1 | 0 | 1 | 0 |
31 Mar 21 | 0 | 0 | 0 | 0 |
31 Dec 20 | 0 | 0 | 0 | 0 |
30 Sep 20 | 0 | 0 | 0 | 0 |
30 Jun 20 | 0 | 0 | 0 | 0 |
31 Mar 20 | 0 | 0 | 0 | 0 |
31 Dec 19 | 0 | 0 | 0 | 0 |
30 Sep 19 | 0 | 0 | 0 | 0 |
30 Jun 19 | 0 | 0 | 0 | 0 |
31 Mar 19 | 0 | 0 | 0 | 0 |
31 Dec 18 | 0 | 0 | 0 | 0 |
30 Sep 18 | 0 | 0 | 0 | 0 |
30 Jun 18 | 0 | 0 | 0 | 0 |
31 Mar 18 | 0 | 0 | 0 | 0 |
31 Dec 17 | 0 | 0 | 0 | 0 |
30 Sep 17 | 0 | 0 | 0 | 0 |
30 Jun 17 | 0 | 0 | 0 | 0 |
31 Mar 17 | 0 | 0 | 0 | 0 |
31 Dec 16 | 0 | 0 | 0 | 0 |
30 Sep 16 | 0 | 0 | 0 | 0 |
30 Jun 16 | 0 | -1 | 0 | 0 |
31 Mar 16 | 0 | -1 | 0 | 0 |
31 Dec 15 | 0 | -1 | 0 | 0 |
Quality Earnings: E1Z is currently unprofitable.
Growing Profit Margin: E1Z is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: E1Z is unprofitable, and losses have increased over the past 5 years at a rate of 66.4% per year.
Accelerating Growth: Unable to compare E1Z's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: E1Z is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.3%).
Return on Equity
High ROE: E1Z has a negative Return on Equity (-129.24%), as it is currently unprofitable.